Iridex Announces the Publication of Two-Year Independent Study Supporting Benefits of MicroPulse® Technology for Early to Advanced Glaucoma
Study reports sustained IOP reduction and reduced medication burden over 24 months Study reports sustained IOP reduction and reduced medication burden over 24 months